Assistant Professor, Surgery, University of Texas Medical Branch SOM
Vascular Surgery
Charlie Cheng, MD is an expert in the field of Vascular Surgery. He researched medicine at Baylor College of Medicine. He received awards:"CMS Meaningful Use Stage 1 Certification". Charlie Cheng, MD is registered with Medicare and accepts Medicare payments.
Schools
Eastern Virginia Medical School
Procedures Preformed
- Aortic Repair, Open or Repair of Arterial Aneurysm, Open
- Arteriovenous Fistula Repair
- Arteriovenous Shunt Creation
- Carotid Artery Stent Placement
- View All
Conditions Treated
- Abdominal Aortic Aneurysm (AAA)
- Acute Deep Vein Thrombosis (DVT)
- Acute Venous Embolism Thrombosis
- Aortic Aneurysm
- View All
Doctors Specialties
- General Surgery
- Vascular Surgery
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Amerigroup (Wellpoint)
- Assurant Health
- Blue Card PPO
- Blue Advantage HMO
- Blue Choice
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Commercial Insurance Company
- Emblem Health
- Federal Employee Program (FEP)
- GEHA
- Health Alliance
- Humana
- Medica
- Medicaid
- Medicare MCR
- Molina
- MultiPlan PPO
- PHCS Network PPO
- Principal Life
- Tricare
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
- Worker's Compensation WC
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Baylor College of Medicine
-
Eastern Virginia Medical School
Drug Facts
NPI NUMBER |
|
1073770038 |
NPPES Provider LastName |
|
CHENG |
NPPES Provider FirstName |
|
CHARLIE |
NPPES Provider ZIPCode |
|
775550735 |
NPPES Provider State |
|
TX |
Specialty Description |
|
Vascular Surgery |
Total Claim Count |
|
254.0 |
Distinct Opioid Count |
|
1.0 |
Opioid Claim Count |
|
42.0 |
Percent Opioid Claims |
|
16.54 |
Helpful Reviews
Give
Anonymous Review
Medicare Facts
National Provider Identifier [NPI] |
1073770038 |
Last Name Of The Provider |
CHENG |
First Name Of The Provider |
CHARLIE |
View All |
|
Similar Doctors
Doctor Directory | TOS | twitter | FB | Angel | blog